Pfizer Earnings: Our Pipeline View Is Incrementally Positive
· morningstar.com · popularity 15/100 · 0 similar stories today
Read the original at morningstar.com →
Summary
Our updated model points to likely revenue declines in 2028 and 2029 and a return to low-single-digit growth in the early 2030s. Key Morningstar …
Found in: Stocks. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 21.